Europe · Markets & Finance · Manager Magazin

Ottobock: Warum Aktionärsschützer den Prothesenhersteller verklagen

Published by Manager Magazin · Germany 13 h ago

Der Prothesenkonzern Ottobock macht noch immer 10 Prozent seines Umsatzes in Russland. Ob er Anleger beim Börsengang ausreichend über die Risiken der Geschäfte aufgeklärt hat,…

Read the full article on Manager Magazin Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.manager-magazin.de)

Also worth reading

City A.M.

FIVE AT FIVE: Pennon hits shareholders for £550m, Shell upgrades and Inchcape gets the chop

FXStreet

Ottobock: Warum Aktionärsschützer den Prothesenhersteller verklagen

Share

Also worth reading

Virgin Media O2 defends arena deal as £200m price tag disputed

Boots bought by Canada's billionaire Weston family for £6.7bn

US oil trader takes $2bn gamble on tankers as carriers steer clear of Hormuz

European shares, euro fall as energy shock, fiscal worries bite

FIVE AT FIVE: Pennon hits shareholders for £550m, Shell upgrades and Inchcape gets the chop

Not the Fed, not the ECB: The Euro's biggest problem is France's €283.7 billion debt wall